Source: ALL
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs11012476
rs11012476
NEBL
A 0.700 GeneticVariation GWASCAT Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs. 28388302

2017
dbSNP: rs11087114
rs11087114
MACROD2 ; MACROD2-AS1
A 0.700 GeneticVariation GWASCAT Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS). 29206233

2017
dbSNP: rs2280828
rs2280828 		C 0.700 GeneticVariation GWASCAT Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS). 29206233

2017
dbSNP: rs2907092
rs2907092
CTNND2
G 0.700 GeneticVariation GWASCAT Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS). 29206233

2017
dbSNP: rs34213790
rs34213790
HLA-B
A 0.700 GeneticVariation GWASCAT Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population. 28062682

2017
dbSNP: rs4761669
rs4761669 		G 0.700 GeneticVariation GWASCAT Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS). 29206233

2017
dbSNP: rs4842407
rs4842407 		C 0.700 GeneticVariation GWASCAT Genome-Wide Association and Replication Study of Hepatotoxicity Induced by Antiretrovirals Alone or with Concomitant Anti-Tuberculosis Drugs. 28388302

2017
dbSNP: rs5010528
rs5010528
HLA-B ; HLA-C
G 0.700 GeneticVariation GWASCAT Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population. 28062682

2017
dbSNP: rs6139258
rs6139258
RNF24
C 0.700 GeneticVariation GWASCAT Genome-wide association study of nevirapine hypersensitivity in a sub-Saharan African HIV-infected population. 28062682

2017
dbSNP: rs73112098
rs73112098 		G 0.700 GeneticVariation GWASCAT Genome-wide admixture and association study of subclinical atherosclerosis in the Women's Interagency HIV Study (WIHS). 29206233

2017
dbSNP: rs10025419
rs10025419
EMCN
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10041590
rs10041590
C5orf17
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10054178
rs10054178
C5orf17
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10056373
rs10056373
C5orf17
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10119043
rs10119043 		0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10178992
rs10178992
UGT1A10 ; UGT1A8 ; UGT1A7 ; UGT1A6 ; UGT1A5 ; UGT1A9 ; UGT1A4 ; UGT1A3
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10179091
rs10179091
UGT1A10 ; UGT1A8 ; UGT1A7 ; UGT1A6 ; UGT1A5 ; UGT1A9 ; UGT1A4 ; UGT1A3
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10827209
rs10827209
NRP1
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10892961
rs10892961
CLMP
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10929301
rs10929301
UGT1A10 ; UGT1A8 ; UGT1A7 ; UGT1A6 ; UGT1A5 ; UGT1A9 ; UGT1A4 ; UGT1A3 ; LOC100286922
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs10929302
rs10929302
UGT1A10 ; UGT1A8 ; UGT1A7 ; UGT1A6 ; UGT1A5 ; UGT1A9 ; UGT1A4 ; UGT1A3 ; LOC100286922
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs11011237
rs11011237
TACC1P1
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs11218976
rs11218976
CLMP
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs11228672
rs11228672
OR5M13P
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015
dbSNP: rs113051092
rs113051092
C5orf17
0.700 GeneticVariation GWASCAT Genomewide association study of tenofovir pharmacokinetics and creatinine clearance in AIDS Clinical Trials Group protocol A5202. 26148204

2015